MICS: gauge width impacts wound

Article

Gauges and knives used during microincision cataract surgery (MICS) should be of equal thickness, according to a study published in the July 2008 issue of the Journal of Cataract & Refractive Surgery.

Gauges and knives used during microincision cataract surgery (MICS) should be of equal thickness, according to a study published in the July 2008 issue of the Journal of Cataract & Refractive Surgery.

Dr Keisuke Kimura of Kosei Chuo Hospital, Tokyo, Japan and colleagues evaluated the impact of gauge thickness on wound measurement by measuring wound width before and after intraocular lens (IOL) implantation. Subjects were divided into groups with incisions of either 2.2 mm or 2.4 mm, and the team used either a 0.15 mm gauge (F-gauge), which was the same thickness as the knives used during surgery, or a 0.35 mm gauge (A-gauge) to measure the wounds.

The F-gauge measured the 2.2 mm incision wound as 2.20±0.03 mm before IOL implantation, compared with the A-gauge pre-insertion measurement of 2.16±0.05 mm; after insertion of the IOL, the F-gauge measured the wound width as 2.41±0.08 mm, compared with the A-gauge measurement of 2.35±0.09 mm. The F-gauge measured the 2.4 mm incision wound as 2.39±0.04 mm before IOL implantation, compared with the A-gauge pre-insertion measurement of 2.31±0.06 mm. The post-implantation wound width was measured as >2.5 mm for both groups.

The researchers noted that measurement errors increase when the gauge used is thicker than the knife; they concluded that a thicker gauge is less reliable for measuring wound width than is a gauge of equal thickness to the knife.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.